TRIESENCE for Eye Pain

Age: 18+
Sex: Any
Trial Phase: Phase 3
Sponsor: Harrow Inc
Pivotal Trial (Near Approval)This treatment is in the last trial phase before FDA approval
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is designed to evaluate the safety and efficacy of TRIESENCE® (triamcinolone acetonide injectable suspension) in patients undergoing ophthalmic procedures. The trial will assess clinical outcomes associated with the use of the investigational product and support a supplemental New Drug Application (sNDA). Participants will receive the study drug as part of a controlled clinical setting, and outcomes related to safety, tolerability, and effectiveness will be evaluated.

Are You a Good Fit for This Trial?

This trial is for people who have eye inflammation and pain after eye surgery (postoperative uveitis). Participants must be recovering from an ophthalmic procedure and meet other health requirements set by the study team.

Inclusion Criteria

Able and willing to provide informed consent and comply with study procedures
I am 18 years old or older.
I am scheduled for cataract surgery with lens implantation.
See 3 more

Exclusion Criteria

Participation in another clinical trial within a restricted timeframe
Known hypersensitivity to triamcinolone acetonide or formulation components
I currently have an eye infection or inflammation.
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • TRIESENCE (triamcinolone acetonide injectable suspension)

Trial Overview

The study compares TRIESENCE (a steroid injection given in the eye) to a sham treatment (no active medication) to see if it helps reduce inflammation and pain after eye surgery. Patients are randomly assigned to one of these groups.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: TRIESENCE Treatment ArmExperimental Treatment1 Intervention
Group II: Placebo Comparator: Placebo (Sham) Control ArmPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Harrow Inc

Lead Sponsor

Trials
1
Recruited
60+